Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription


3 Am Heart J
4 Am J Cardiol
3 Arterioscler Thromb Vasc Biol
3 Atherosclerosis
1 Cardiovasc Res
9 Catheter Cardiovasc Interv
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Interv
3 Circ J
12 Circ Res
3 Circulation
2 Heart
2 Hypertension
3 Int J Cardiol
5 J Am Coll Cardiol
2 J Clin Endocrinol Metab
2 Lancet
2 Mayo Clin Proc
5 PLoS One
1 Thromb Haemost

    Am Heart J

  1. COOPER JG, Ferguson J, Donaldson LA, Black KMM, et al
    Could paramedics use the HEART Pathway to identify patients at low-risk of myocardial infarction in the prehospital setting?
    Am Heart J. 2024;271:182-187.
    >> Share

  2. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    >> Share

  3. DEHGHANI P, Singh J, Mancini GBJ, Stanberry L, et al
    Angiographic characteristics of Patients with STEMI and COVID-19 - Insights from NACMI Registry.
    Am Heart J. 2024 Feb 21:S0002-8703(24)00039-5. doi: 10.1016/j.ahj.2024.
    >> Share

    Am J Cardiol

    Timing of Revascularization in Patients with Acute Coronary Syndrome: Why Is Earlier Better?
    Am J Cardiol. 2024 Apr 22:S0002-9149(24)00314.
    >> Share

  5. MANNINA C, Kini A, Carbone A, Neibart E, et al
    Management of Systemic Inflammatory Response Syndrome after Cardiovascular Interventions. Diagnostic, Prognostic and Therapeutic Implications.
    Am J Cardiol. 2024 Apr 20:S0002-9149(24)00270.
    >> Share

  6. YANG Z, Tiemuerniyazi X, Huang S, Song Y, et al
    Partial CArdiac Denervation to prevent PostOperative Atrial Fibrillation after coronary artery bypass grafting (pCAD-POAF): study protocol for a randomized controlled trial.
    Am J Cardiol. 2024 Apr 20:S0002-9149(24)00278.
    >> Share

  7. GARG M, Creechan P, Sadeghpour A, Abramov D, et al
    Trends of Cardiovascular Disease Related Mortality in Breast Cancer in the United States From 1999 to 2019.
    Am J Cardiol. 2024 Apr 19:S0002-9149(24)00276.
    >> Share

    Arterioscler Thromb Vasc Biol

  8. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
    Arterioscler Thromb Vasc Biol. 2024;44:1144-1155.
    >> Share

  9. GHOUSE J, Ahlberg G, Rand SA, Olesen MS, et al
    Potential Influence of Risk Factor Control on the Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320990.
    >> Share

  10. SOUCY A, Potts C, Kaija A, Harrington A, et al
    Effects of a Global Rab27a Null Mutation on Murine PVAT and Cardiovascular Function.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320969.
    >> Share


  11. MELNES T, Bogsrud MP, Christensen JJ, Rundblad A, et al
    Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
    Atherosclerosis. 2024;392:117507.
    >> Share

  12. ENGEBRETSEN I, Bugge C, Stovring H, Husebye E, et al
    Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
    Atherosclerosis. 2024;393:117550.
    >> Share

  13. XIAO J, Wei H, Gao Z, Chen L, et al
    Differential age-specific associations of LDL cholesterol and body mass index with coronary heart disease.
    Atherosclerosis. 2024;393:117542.
    >> Share


  14. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

    Cardiovasc Res

  15. SUN Q, Chen W, Wu R, Tao B, et al
    Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.
    Cardiovasc Res. 2024 Apr 26:cvae075. doi: 10.1093.
    >> Share

    Catheter Cardiovasc Interv

  16. SAKAI K, Storozhenko T, Mizukami T, Ohashi H, et al
    Impact of vessel volume on thermodilution measurements in patients with coronary microvascular dysfunction.
    Catheter Cardiovasc Interv. 2024;103:885-896.
    >> Share

  17. BUCHANAN CE, Iskander M, Anwaruddin S, Mason PJ, et al
    Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
    Catheter Cardiovasc Interv. 2024 Apr 8. doi: 10.1002/ccd.31038.
    >> Share

  18. AL-OGAILI A, Alexandrou M, Rempakos A, Mutlu D, et al
    Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31019.
    >> Share

  19. SANTOS LM, Campos CM, Garcia-Garcia HM, Godinho RR, et al
    Concordance between vessel-specific and vascular territory coronary functional assessment: A comparison of quantitative flow ratio and myocardial perfusion scintigraphy.
    Catheter Cardiovasc Interv. 2024 Apr 1. doi: 10.1002/ccd.31021.
    >> Share

  20. CASE BC, Bazarbashi N, Johnson A, Rogers T, et al
    A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique.
    Catheter Cardiovasc Interv. 2024;103:917-923.
    >> Share

  21. YE C, Ma X, Shi B, Yan R, et al
    Obesity is associated with acute kidney injury in ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention: A national representative cohort study.
    Catheter Cardiovasc Interv. 2024;103:897-908.
    >> Share

  22. GIACOBBE F, Valente E, Morena A, Nebiolo M, et al
    Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: A network meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:843-855.
    >> Share

  23. SATO T, Matsumura M, Yamamoto K, Shlofmitz E, et al
    Prevalence and anatomical factors associated with stent under-expansion in non-severely calcified lesions.
    Catheter Cardiovasc Interv. 2024;103:833-842.
    >> Share

  24. REMPAKOS A, Alexandrou M, Mutlu D, Choi JW, et al
    Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Apr 17. doi: 10.1002/ccd.31045.
    >> Share

    Circ Arrhythm Electrophysiol

  25. MARTINEZ-FALGUERA D, Aranyo J, Teis A, Ferrer-Curriu G, et al
    Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction Scar.
    Circ Arrhythm Electrophysiol. 2024 Apr 26:e012517.
    >> Share

    Circ Cardiovasc Interv

  26. YIDILISI A, Chen D, Zhang Y, Pu J, et al
    Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Outcome in Patients With ST-Segment-Elevation Myocardial Infarction.
    Circ Cardiovasc Interv. 2024 Apr 25:e013899.
    >> Share

    Circ J

  27. DATE A
    Comprehensive Cardiac Rehabilitation for Patients With Myocardial Infarction?- Impact on Prognosis in Patients With Low Exercise Capacity.
    Circ J. 2024 Apr 20. doi: 10.1253/circj.CJ-24-0245.
    >> Share

  28. FUJIYOSHI A, Kohsaka S, Hata J, Hara M, et al
    JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease.
    Circ J. 2024;88:763-842.
    >> Share

  29. KWON HW, Song MK, Lee SY, Kim GB, et al
    Risk Factors for Coronary Artery Complications After Prosthetic Pulmonary Valve Implantation in Patients With Congenital Heart Disease.
    Circ J. 2024;88:652-662.
    >> Share

    Circ Res

  30. RIGGS DW, DuPre NC, James P, Rai SN, et al
    Association of Ecoregion Distribution of Greenness With Cardiovascular Mortality: A Longitudinal Ecological Study in the United States.
    Circ Res. 2024;134:1221-1223.
    >> Share

  31. R V O SALERNO P, Chen Z, Bourges-Sevenier B, Qian A, et al
    Transportation-Related Carbon Footprint of Coronary Heart Disease Ambulatory Care in the United States.
    Circ Res. 2024;134:1218-1220.
    >> Share

  32. KEITH RJ, Hart JL, Bhatnagar A
    Greenspaces And Cardiovascular Health.
    Circ Res. 2024;134:1179-1196.
    >> Share

  33. SINGH N, Areal AT, Breitner S, Zhang S, et al
    Heat and Cardiovascular Mortality: An Epidemiological Perspective.
    Circ Res. 2024;134:1098-1112.
    >> Share

  34. WILLIAMS VA, Perreault LR, Yazbeck CT, Micovic NA, et al
    Impact of Wildfires on Cardiovascular Health.
    Circ Res. 2024;134:1061-1082.
    >> Share

  35. BLAUSTEIN JR, Quisel MJ, Hamburg NM, Wittkopp S, et al
    Environmental Impacts on Cardiovascular Health and Biology: An Overview.
    Circ Res. 2024;134:1048-1060.
    >> Share

  36. BONANNI LJ, Newman JD
    Personal Strategies to Reduce the Cardiovascular Impacts of Environmental Exposures.
    Circ Res. 2024;134:1197-1217.
    >> Share

  37. PAN Z, Gong T, Liang P
    Heavy Metal Exposure and Cardiovascular Disease.
    Circ Res. 2024;134:1160-1178.
    >> Share

  38. KHRAISHAH H, Chen Z, Rajagopalan S
    Understanding the Cardiovascular and Metabolic Health Effects of Air Pollution in the Context of Cumulative Exposomic Impacts.
    Circ Res. 2024;134:1083-1097.
    >> Share

    Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk.
    Circ Res. 2024;134:1136-1159.
    >> Share

  40. HAMBURG NM, Moore KJ
    Introduction to the Compendium On Environmental Impacts on Cardiovascular Health and Biology.
    Circ Res. 2024;134:1047.
    >> Share

  41. MUNZEL T, Molitor M, Kuntic M, Hahad O, et al
    Transportation Noise Pollution and Cardiovascular Health.
    Circ Res. 2024;134:1113-1135.
    >> Share


  42. GIRI J, Kaneko T
    Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
    Circulation. 2024;149:1339-1340.
    >> Share

  43. SHAH SH, Gerszten RE
    Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
    Circulation. 2024;149:1323-1325.
    >> Share

  44. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
    Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
    >> Share


  45. BEVAN GH, Buber J
    Exercise intolerance in a man with ischaemic cardiomyopathy and biventricular pacing.
    Heart. 2024;110:693-750.
    >> Share

  46. JO SH, Kim H, Kim HJ, Lee MH, et al
    Percutaneous coronary intervention versus medical therapy in stable angina: a matched cohort study.
    Heart. 2024 Jan 29:heartjnl-2023-323541. doi: 10.1136/heartjnl-2023-323541.
    >> Share


  47. BUGEJA A, Girard C, Sood MM, Kendall CE, et al
    Sex-Related Disparities in Cardiovascular Outcomes Among Older Adults With Late-Onset Hypertension.
    Hypertension. 2024 Apr 25. doi: 10.1161/HYPERTENSIONAHA.124.22870.
    >> Share

  48. LIBERMAN AL, Razzak J, Lappin RI, Navi BB, et al
    Risk of Major Adverse Cardiovascular Events After Emergency Department Visits for Hypertensive Urgency.
    Hypertension. 2024 Apr 25. doi: 10.1161/HYPERTENSIONAHA.124.22885.
    >> Share

    Int J Cardiol

  49. MIURA H, Koseki M, Ide S, Asaumi Y, et al
    Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction.
    Int J Cardiol. 2024 Apr 23:132099. doi: 10.1016/j.ijcard.2024.132099.
    >> Share

  50. AL A, Babayigit E, Gorenek B
    Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
    Int J Cardiol. 2024;406:132079.
    >> Share

  51. GIRERD N
    The underappreciated value of resting heart rate in post-myocardial infarction follow-up.
    Int J Cardiol. 2024 Apr 19:132059. doi: 10.1016/j.ijcard.2024.132059.
    >> Share

    J Am Coll Cardiol

  52. KOREN MJ, Rodriguez F, East C, Toth PP, et al
    An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024 Apr 7:S0735-1097(24)06624.
    >> Share

  53. HUANG T
    Low Delta Wave Activity During Sleep Promotes Cardiovascular Disease Risk: What's Next?
    J Am Coll Cardiol. 2024;83:1685-1687.
    >> Share

  54. BOULESTREAU R, Spiewak M, Januszewicz A, Kreutz R, et al
    Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1688-1701.
    >> Share

  55. QUESADA O, Crousillat D, Rodriguez F, Bravo-Jaimes K, et al
    Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1702-1712.
    >> Share

  56. PICCOLO R, Angellotti D, Simonetti F, Leone A, et al
    Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024;83:1713-1715.
    >> Share

    J Clin Endocrinol Metab

  57. KAJIKAWA M, Maruhashi T, Kishimoto S, Yamaji T, et al
    A Body Shape Index as a Simple Anthropometric Marker of Abdominal Obesity and Risk of Cardiovascular Events.
    J Clin Endocrinol Metab. 2024 Apr 25:dgae282. doi: 10.1210.
    >> Share

    Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
    J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
    >> Share


  59. MCCARTHY CP, Wasfy JH, Januzzi JL Jr
    Is Myocardial Infarction Overdiagnosed?
    JAMA. 2024 Apr 24. doi: 10.1001/jama.2024.5235.
    >> Share


  60. MONTI CB, Palmisano A
    Coronary sinus reducer: a new hope for refractory angina?
    Lancet. 2024;403:1514-1515.
    >> Share

  61. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader FA, et al
    Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
    Lancet. 2024;403:1543-1553.
    >> Share

    Mayo Clin Proc

  62. SPARKS JR, Wang X, Lavie CJ, Zhang J, et al
    Cardiorespiratory Fitness as a Predictor of Non-Cardiovascular Disease and Non-Cancer Mortality in Men.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00599.
    >> Share

  63. DABROWSKI EJ, Kurasz A, Pasierski M, Pannone L, et al
    Surgical Coronary Revascularization in Patients With Underlying Atrial Fibrillation: State-of-the-Art Review.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00606.
    >> Share

    PLoS One

  64. OSTOVANEH MR, Hughes TM, Wu CO, McClelland RL, et al
    Deep phenotyping of dementia in a multi-ethnic cardiovascular cohort: The Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2024;19:e0298952.
    >> Share

  65. SHI R, Meng W, Liu Z, Xue W, et al
    Exploring acupuncture as a treatment for insomnia in perimenopausal women with stable angina pectoris: A protocol for a randomized, double-blind, placebo-controlled clinical trial.
    PLoS One. 2024;19:e0301827.
    >> Share

  66. CUI J, Wang Q, Li M
    Xinnaotongluo liquid protects H9c2 cells from H/R-induced damage by regulating MDM2/STEAP3.
    PLoS One. 2024;19:e0302407.
    >> Share

  67. HENDRICKSON KW, Cirulis MM, Burk RE, Lanspa MJ, et al
    Identifying predictors and determining mortality rates of septic cardiomyopathy and sepsis-related cardiogenic shock: A retrospective, observational study.
    PLoS One. 2024;19:e0299876.
    >> Share

  68. CHEN J, Huang W, Liang N
    Blood glucose fluctuation and in-hospital mortality among patients with acute myocardial infarction: eICU collaborative research database.
    PLoS One. 2024;19:e0300323.
    >> Share

    Thromb Haemost

  69. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016